Table 1 Table of clinical and anthropometric measures of the patient compared to Control Group (CG). F: Female; M: Male; BMI: Body Mass Index; NCS MN: Nervous Conduction Speed Median Nerve
Clinical data | Patient | Control group (n = 37) |
|---|---|---|
Fnnirs evaluation date | 01/31/2020 | – |
Gener (f, prop) | F | 15 (0.36) |
Age (years) | 43 | 35.6 ± 17.3 |
Height (cm) | 166 | 169.1 ± 9.86 |
Weight (kg) | 85 | 72.5 ± 14.8 |
BMI (Kg.m-2) | 30.8 | 25.2 ± 4.2 |
Body fat (%) | 26.13 | 19.4 ± 5.4 |
Primary pathologies | Transverse myelitis | No disease |
Secondary pathologies | Von willebrand’s disease, ehlers-danlos syndrome, autonomic dysfunction, sulcus vocalis and thyroid nodule | No disease |
Current medication (doses) | Morphine (36 mg/day), pregabalin (375 mg/day), omeprazole (40 mg/day), amitriptyline (75 mg/day), tranexamic acid (500 mg/day), fludrocortisone (0.2 mg/day), roll on lidocaine | No medications |
Median ncv (m.s−1) | 54.6 | 49.8 ± 3.5 |
Right n11 latency | No tested | – |
Left n11 latency | 10.83 | 11.79 ± 1.1 |